Search by Drug Name or NDC
NDC 00023-4291-10 LASTACAFT 2.5 mg/mL Details
LASTACAFT 2.5 mg/mL
LASTACAFT is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is ALCAFTADINE.
MedlinePlus Drug Summary
Ophthalmic alcaftadine is used to relieve the itching of allergic pinkeye. Alcaftadine is in a class of medications called antihistamines. It works by blocking histamine, a substance in the body that causes allergic symptoms.
Related Packages: 00023-4291-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Alcaftadine Ophthalmic
Product Information
| NDC | 00023-4291 |
|---|---|
| Product ID | 0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6 |
| Associated GPIs | 86802004002020 |
| GCN Sequence Number | 066954 |
| GCN Sequence Number Description | alcaftadine DROPS 0.25 % OPHTHALMIC |
| HIC3 | Q6R |
| HIC3 Description | EYE ANTIHISTAMINES |
| GCN | 29389 |
| HICL Sequence Number | 037330 |
| HICL Sequence Number Description | ALCAFTADINE |
| Brand/Generic | Brand |
| Proprietary Name | LASTACAFT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | alcaftadine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | ALCAFTADINE |
| Labeler Name | Allergan, Inc. |
| Pharmaceutical Class | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022134 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 00023-4291-10 (00023429110)
| NDC Package Code | 0023-4291-10 |
|---|---|
| Billing NDC | 00023429110 |
| Package | 2 BOTTLE, PLASTIC in 1 CARTON (0023-4291-10) / 5 mL in 1 BOTTLE, PLASTIC |
| Marketing Start Date | 2021-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL a3002410-4bf1-4182-9d7c-8193eb7cd215 Details
Warnings
For external use only
Do not use
■ if solution changes color or becomes cloudy
■ if you are sensitive to any ingredient in this product
■ to treat contact lens related irritation
When using this product
■ do not touch tip of container to any surface to avoid contamination
■ remove contact lenses before use
■ wait at least 10 minutes before reinserting contact lenses after use
■ do not wear a contact lens if your eye is red
Directions
Inactive ingredients
PRINCIPAL DISPLAY PANEL
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
| LASTACAFT
alcaftadine solution/ drops |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - Allergan, Inc. (144796497) |
Revised: 8/2022
Document Id: 3110f1f0-8f7d-425b-8ed5-99673f085be6
Set id: a3002410-4bf1-4182-9d7c-8193eb7cd215
Version: 3
Effective Time: 20220810